Cassava Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-24.34	-97.22	-76.25	-32.39	-6.33	Upgrade
Depreciation & Amortization	1.13	1.53	1.3	0.53	0.02	Upgrade
Loss (Gain) From Sale of Assets	-	-	-	-	-0.35	Upgrade
Stock-Based Compensation	16.29	4.59	2.07	1.76	0.99	Upgrade
Other Operating Activities	-108.18	-	-	-	-	Upgrade
Change in Accounts Payable	-2.92	6.9	-3.45	6.22	0.46	Upgrade
Change in Other Net Operating Assets	1.09	2.18	-1.19	-6.32	-0.17	Upgrade
Operating Cash Flow	-116.93	-82.03	-77.51	-30.2	-5.38	Upgrade
Capital Expenditures	-0.1	-0.41	-2.71	-22.21	-	Upgrade
Sale of Property, Plant & Equipment	-	-	-	-	0.36	Upgrade
Investing Cash Flow	-0.1	-0.41	-2.71	-22.21	0.36	Upgrade
Issuance of Common Stock	124.47	2.56	47.8	192.34	75.45	Upgrade
Financing Cash Flow	124.47	2.56	47.8	192.34	75.45	Upgrade
Net Cash Flow	7.44	-79.88	-32.42	139.93	70.43	Upgrade
Free Cash Flow	-117.03	-82.44	-80.23	-52.41	-5.38	Upgrade
Free Cash Flow Per Share	-2.51	-1.97	-2.00	-1.33	-0.21	Upgrade
Levered Free Cash Flow	-72.99	-51.57	-54	-40.39	-2.95	Upgrade
Unlevered Free Cash Flow	-72.99	-51.57	-54	-40.39	-2.95	Upgrade
Change in Working Capital	-1.83	9.08	-4.64	-0.1	0.29	Upgrade

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q